MicroRNA-138 is a prognostic biomarker for triple-negative breast cancer and promotes tumorigenesis via TUSC2 repression
Breast cancer manifests as a spectrum of subtypes with distinct molecular signatures, and different responses to treatment. Of these subtypes, triple-negative breast cancer (TNBC) has the worst prognoses and limited therapeutic options. Here we report aberrant expression of microRNA-138 (miR-138) in...
Saved in:
Main Authors: | Nama, Srikanth, Muhuri, Manish, Di Pascale, Federica, Quah, Shan, Aswad, Luay, Fullwood, Melissa, Sampath, Prabha |
---|---|
其他作者: | School of Biological Sciences |
格式: | Article |
語言: | English |
出版: |
2020
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/142966 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
由: Nama, S., et al.
出版: (2022) -
mRNA Destabilization Is the Dominant Effect of Mammalian MicroRNAs by the Time Substantial Repression Ensues
由: Eichhorn, Stephen W., et al.
出版: (2016) -
TRANSCRIPTIONAL REGULATION OF ONCOMIR-138 IN MALIGNANT GLIOMAS
由: DI PASCALE FEDERICA
出版: (2017) -
MicroRNA trimming in the nervous system
由: Lee, Li Ming
出版: (2013) -
MicroRNA and heart failure
由: Wong, L.L, et al.
出版: (2020)